Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
Fasedienol Nasal Spray - Placebo Nasal Spray Phase 2 Results Expected
Fasedienol Nasal Spray - Placebo Nasal Spray • Social Anxiety Disorder
Target Indication
Social Anxiety Disorder
Clinical Trial
Last updated: 12/4/2025
VTGN
Vistagen Therapeutics, Inc.
